Value of anticardiolipin antibodies for monitoring disease activity in systemic lupus erythematosus and other rheumatic diseases

Clinical Rheumatology

Volumn 16, Issue 6, 1997, Pages 562-569

  Buttgereit, F ^a   Grunewald T ^b   Schuler Maue W ^b   Burmester, G R ^b   Hiepe, F ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

Anticardiolipin antibodies; Monitoring Disease Activity; Rheumatic Diseases; SLE

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; REACTIVE ARTHRITIS; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; COMPLEMENT SYSTEM PROTEINS; DNA; FEMALE; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RHEUMATIC DISEASES;

EID: 2642672808     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02247796     Document Type: Article

References (22)

1. Tsakiris DA, de Moerloose P. Antiphospholipid syndrome: a new clinical entity? Schweiz Med Wochenschr 1993;123:2183-90.
2. Fort GJ, Cowchock FS, Abruzzo JL et al. Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum 1987; 30: 752-60.
3. Sturfelt G, Nived O, Norberg R et al. Anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1987; 30: 382-8.
4. Doria A, Ruffatti A, Calligaro A et al. Antiphospholipid antibodies in mixed connective tissue disease. Clin Rheumatol 1992; 11:48-50.
5. Jedryka-Goral A, Jagiello P, D'Cruz DP et al. Isotype profile and clinical relevance of anticardiolipin antibodies in Sjögren's syndrome. Ann Rheum Dis 1992; 51: 889-91.
6. Cooper RC, Klemp P, Stipp CJ, Brink S. The relationship of anticardiolipin antibodies to disease activity in systemic lupus erythematosus. Br J Rheumatol 1989; 28: 379-82.
7. Nossent JC, Henzen-Logmans SC, Vroom TM et al. Relation between serological data at the time of biopsy and renal histology in lupus nephritis. Rheumatol Int 1991; 11: 77-82.
8. Ishii Y, Nagasawa K, Mayumi T, Niho Y. Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus. Ann Rheum Dis 1990; 49: 387-90.
9. Alarco n-Segóvia D, Deleze M, Oria CV et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989; 68: 353-65.
10. Tan EM, Cohen AA, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1992; 25: 1271-7.
11. Zonana-Nacach A, Salas M, Sánchez L et al. Measurements of clinical activity of systemic lupus erythematosus and laboratory abnormalities: A 12-month prospective study. J Rheumatol 1995; 22: 45-9.
12. Vitali C, Bencivelli W, Isenberg DA et al. Disease activity in Systemic Lupus Erythematosus: Report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992; 10: 541-47.
13. Arnett FC, Edworthy SM, Bloch DE et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
14. Dougados M, van der Linden S, Jublin R et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34:1218-27.
15. Fleiss JL. Statistical methods for rates and proportions. 2nd edition. Wiley, 1981.
16. Dawson-Saunders B, Trapp RG. Basic and clinical biostatistics. Appleton & Lange, 1990.
17. Hughes GRV The antiphospholipid syndrome: ten years on. Lancet 1993; 342:341-4.
18. Ginsburg KS, Liang MH, Newcomer L et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Int Med 1992; 117: 997-1002.
19. Muir KW, Squire IB, Alwan W, Lees KR. Anticardiolipin antibodies in an unselected stroke population. Lancet 1994; 344: 452-6.
20. Vlachoyiannopoulos PG, Krilis SA, Hunt JE et al. Patients with anticardiolipin antibodies with and without antiphospholipid syndrome: their clinical features and 2-glycoprotein-I plasma levels. Eur J Clin Inv 1992; 22: 482-7.
21. Drenkard C, Villa AR, Alarcon-Segóvia D, Pèrez-Vàzquez ME. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J Rheumatol 1994; 21: 1067-72.
22. Asherson RA, Baguley E, Pal C, Hughes GRV. Antiphospholipid syndrome: five year follow up. Ann Rheum Dis 1991; 50: 805-10.